Literature DB >> 19500022

Salivary gland protection with sialagogues: a case study.

Douglas Van Nostrand1, Frank Atkins, Varalakshmi V Bandaru, Shyam P Chennupati, Shari Moreau, Kenneth Burman, Leonard Wartofsky.   

Abstract

BACKGROUND: To decrease the severity and frequency of radiation sialoadenitis, postponement of the use of sialagogues has been proposed for the first 24 hours after (131)I treatment for well-differentiated thyroid cancer. One proposed mechanism is that sialagogues increased salivation and salivary blood flow resulting in greater radioiodine uptake in the salivary glands-a rebound effect. This case study demonstrates no rebound effect.
METHODS: A 33-year-old woman with well-differentiated thyroid cancer desired to know whether she would have a rebound effect if she used sialagogues during the 24-hour period after her (131)I treatment. Salivary images of the parotid glands were initiated 2 hours after the administration of (131)I for her whole body scan. Lemon juice was administered. Background corrected time-activity curves were obtained for both parotid glands. The potential reduction in radiation absorbed dose to the parotid glands secondary to the administration of lemon juice was calculated.
RESULTS: The time-activity curves demonstrated that the (131)I in the right and left parotid glands decreased rapidly after lemon juice by 87% and 83%, respectively, with return to pre-lemon juice levels by 30 and 13 minutes in the right and left parotid glands, respectively. However, at no time during the 1 hour of imaging did the uptake in either parotid gland significantly exceed the pre-lemon juice levels of activity. The potential reduction of radiation absorbed dose to the parotid glands secondary to the use of lemon juice ranged from as much as 30% to 67%.
CONCLUSION: This case study demonstrates 1) an approach to assess whether an individual patient will have increased or decreased radioiodine uptake in the salivary glands after administration of sialagogues without the administration of any additional radioiodine, 2) a decrease of radioiodine uptake in the salivary glands after lemon juice without a rebound effect, and 3) a potential reduction of radiation absorbed dose with administration of sialagogues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500022     DOI: 10.1089/thy.2008.0381

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

Review 1.  Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.

Authors:  E N Klein Hesselink; T P Links
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.

Authors:  Walter Jentzen; Dorothee Balschuweit; Jochen Schmitz; Lutz Freudenberg; Ernst Eising; Thomas Hilbel; Andreas Bockisch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

3.  Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.

Authors:  Hae Won Kim; Byeong-Cheol Ahn; Sang-Woo Lee; Jaetae Lee
Journal:  Thyroid       Date:  2012-04-23       Impact factor: 6.568

Review 4.  RETRACTED ARTICLE: Radiation sialadenitis induced by high-dose radioactive iodine therapy.

Authors:  Shin Young Jeong; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21

5.  The study of external dose rate and retained body activity of patients receiving 131I therapy for differentiated thyroid carcinoma.

Authors:  Haiying Zhang; Ling Jiao; Songye Cui; Liang Wang; Jian Tan; Guizhi Zhang; Yajing He; Shuzhou Ruan; Saijun Fan; Wenyi Zhang
Journal:  Int J Environ Res Public Health       Date:  2014-10-21       Impact factor: 3.390

6.  Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy.

Authors:  Baiqiang Lin; Fuya Zhao; Yang Liu; Jiayu Sun; Jing Feng; Lei Zhao; Haoran Wang; Hongye Chen; Wei Yan; Xiao Guo; Shang Shi; Zhiyong Li; Shuang Wang; Yu Lu; Jianjun Zheng; Yunwei Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-26       Impact factor: 6.055

7.  Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.

Authors:  Walter Jentzen; Marion Richter; James Nagarajah; Thorsten Dirk Poeppel; Wolfgang Brandau; Colin Dawes; Andreas Bockisch; Ina Binse
Journal:  EJNMMI Phys       Date:  2014-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.